Results 231 to 240 of about 36,022 (296)

Heart failure with a preserved ejection fraction: synergy between cardiac and extracardiac mechanisms and effects of novel therapies. [PDF]

Heart Fail Rev
Nassiri S, Handoko ML, van de Bovenkamp AA, van Empel VPM, van Raalte DH, Eringa EC.   +5 more
europepmc   +1 more source

Gips

, 2004
openaire   +1 more source

Comparative Efficacy of Tirzepatide Versus Semaglutide for Weight Loss in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis of Head‐to‐Head Studies

Clinical Obesity, Volume 16, Issue 5, October 2026.
ABSTRACT This systematic review and meta‐analysis aimed to compare the efficacy and safety of tirzepatide versus semaglutide for weight reduction in adults with overweight or obesity. We included randomised controlled trials and observational studies comparing tirzepatide and semaglutide with ≥ 24 weeks of follow‐up.
Giovanna Pagani Paccola, Roberta Fernandes de Oliveira, Matheus Menão Mochetti, Fernanda Pataro Marsola Razera, Rafael Vecchi, Renan Canale Peres Montanher   +5 more
wiley   +1 more source

Glucose and insulin dynamics following low-carbohydrate and low-fat diets in females with lipedema and obesity. [PDF]

Front Cell Dev Biol
Lundanes J, Fischer AS, Dankel SN, Holst JJ, Martins C, Nymo S.   +5 more
europepmc   +1 more source

Impact of GLP-1 and GLP-1/GIP receptor agonists before, during, and after pregnancy: a narrative review. [PDF]

Diabetol Metab Syndr
Zajdenverg L, Santos VM, Rodrigues ACM, Previdelli LK, Negrato CA.   +4 more
europepmc   +1 more source

Exploratory associations between co-occurring opioid and alcohol use disorders and GIP/GLP-1 receptor agonist treatment. [PDF]

Commun Med (Lond)
Qeadan F, McCunn A, Tingey B, Kroth PJ.
europepmc   +1 more source

The incretin-joint axis: weight-independent mechanisms and disease-modifying potential in chronic arthropathies. [PDF]

Rheumatol Adv Pract
Papastathopoulou NS, Neri S, Assirelli E, D'Amuri A, Greco S, Ciaffi J, Ursini F.   +6 more
europepmc   +1 more source

Pharmacological management of obesity: Current landscape and emerging therapies. [PDF]

Indian J Pharmacol
Atal S, Agrawal C, Gupta R, Sadasivam B.
europepmc   +1 more source

The Possible Hematological Cost of Metabolic Success: Do Incretin-Based Therapies Silently Trigger Anemia? [PDF]

Med Sci (Basel)
Mizdrak M, Batistić D, Mizdrak I.
europepmc   +1 more source

GIP(3-30)NH2 – a tool for the study of GIP physiology

Current Opinion in Pharmacology, 2020
Glucose-dependent insulinotropic polypeptide (GIP) is a gut hormone impacting glucose, lipid and bone metabolism through the GIP receptor (GIPR). The GIP system has key species differences complicating the translation of findings from rodent to human physiology.
Mads Bank Lynggaard, Lærke Smidt Gasbjerg, Mikkel Bring Christensen, Filip Krag Knop   +3 more
openaire   +4 more sources